Disease Info Card

Pyruvate Kinase Deficiency

Information about Pyruvate Kinase Deficiency: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Pyruvate Kinase Deficiency

Most recent studies have shown that Pyruvate Kinase Deficiency shares some biological mechanisms with anemia, anemia-hemolytic, anemia-hemolytic-congenital, anemia-hemolytic-congenital-nonspherocytic, anemia-sickle-cell, autoimmune-hemolytic-anemia, deficiency-anaemia, deficiency-diseases, dog-diseases, glucosephosphate-dehydrogenase-deficiency, hemochromatosis, hemolysis-(disorder), hereditary-spherocytosis, icterus, inborn-errors-of-metabolism, iron-overload, malaria, neonatal-jaundice, pyruvate-kinase-deficiency-anaemia, thalassemia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Pyruvate Kinase Deficiency, and have been seen in publications frequently: Amino Acid Transport, Cell Death, Cell Maturation, Coagulation, Drug Resistance, Fibrinolysis, Glycolysis, L-alanine Transport, Localization, Mating, Oxidative Phosphorylation, Pathogenesis, Phagocytosis, Protein Phosphorylation, Proteolysis, Regeneration, Reverse Transcription, Senescence, Translational Initiation, Transport

Quite a number of genes have been found to play important roles in Pyruvate Kinase Deficiency, such as A4GALT, ADA, CAT, CRAT, EPO, G6PD, GSR, HK1, PAEP, PGD, PKLR, PREP, PTPN22, TPI1, UBL4A. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.